Miriam Roberto

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Prostate Cancer

Magnetic Resonance

Radical Prostatectomy

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Francesca Arena, Francesca La Cava, Daniele Faletto, Miriam Roberto, Federico Crivellin, Francesco Stummo, Alessia Adamo, Mariangela Boccalon, Roberta Napolitano, Francesco Blasi, Maximilian Koch, Adrian Taruttis, Erika Reitano
Short-wave infrared fluorescence imaging of near-infrared dyes with robust end-tail emission using a small-animal imaging device. PNAS nexus 2 (8) (2023)
Pietro Irrera, Miriam Roberto, Lorena Consolino, Annasofia Anemone, Daisy Villano, Victor Navarro-Tableros, Antonella Carella, Walter Dastrù, Silvio Aime, Dario Livio Longo
Effect of Esomeprazole Treatment on Extracellular Tumor pH in a Preclinical Model of Prostate Cancer by MRI-CEST Tumor pH Imaging. Metabolites 13 (1) (2022)
Pietro Irrera, Lorena Consolino, Miriam Roberto, Martina Capozza, Chetan Dhakan, Antonella Carella, Alessia Corrado, Daisy Villano, Annasofia Anemone, Victor Navarro-Tableros, Martina Bracesco, Walter Dastrù, Silvio Aime, Dario Livio Longo
In Vivo MRI-CEST Tumor pH Imaging Detects Resistance to Proton Pump Inhibitors in Human Prostate Cancer Murine Models. Cancers 14 (19) (2022)
Pietro Irrera, Miriam Roberto, Lorena Consolino, Annasofia Anemone, Daisy Villano, Victor Navarro-Tableros, Antonella Carella, Walter Dastrù, Silvio Aime, Dario Livio Longo
Effect of Esomeprazole Treatment on Extracellular Tumor pH in a Preclinical Model of Prostate Cancer by MRI-CEST Tumor pH Imaging. Metabolites 13 (1) (2022)
Pietro Irrera, Miriam Roberto, Lorena Consolino, Annasofia Anemone, Daisy Villano, Victor Navarro-Tableros, Antonella Carella, Walter Dastrù, Silvio Aime, Dario Livio Longo
Effect of Esomeprazole Treatment on Extracellular Tumor pH in a Preclinical Model of Prostate Cancer by MRI-CEST Tumor pH Imaging. Metabolites 13 (1) (2022)